Join to view full profile
601 Elmwood AveRochester, NY 14642
Phone+1 585-275-2542
Fax+1 585-273-1255
Dr. Thornton is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterResidency, Neurology, 1989 - 1991
Oregon Health & Science University (OHSU Health)Residency, Neurology, 1982 - 1985
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1981 - 1982
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1981
Certifications & Licensure
OR State Medical License 1983 - Present
NY State Medical License 1989 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
Publications & Presentations
PubMed
- Elimination of myotonia improves myopathy in a muscleblind-like knockout model of myotonic dystrophy.Matthew T Sipple, Sakura A Hamazaki, Vanessa Todorow, Lily A Cisco, Katherine M Lupia
Nature Communications. 2026-07-08 - 2 citationsDelpacibart etedesiran improves the molecular pathology of myotonic dystrophy type 1 in the phase 1/2 MARINA study.Tanya T Kwan, Qingying Meng, Nathaniel Delos Santos, Nicholas E Johnson, Charles A Thornton
Molecular Therapy. 2026-07-01 - Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.Valeria A Sansone, Andrea Lizio, Carola R Ferrari Aggradi, Lucia C Greco, Cynthia Gagnon
Muscle & Nerve. 2026-07-01
Press Mentions
Celebrating Decades of Advances in Myotonic Dystrophy ResearchSeptember 17th, 2024- Triplet Therapeutics Announces Participation in Natural History Study of Myotonic Dystrophy Type 1August 18th, 2020
Grant Marks Two Decades of NIH Support for Muscular Dystrophy ResearchFebruary 25th, 2019
Grant Support
- Pharmacodynamic Biomarker of Myotonic DystrophyUNIVERSITY OF ROCHESTER2023–2028
- Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal)VIRGINIA COMMONWEALTH UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
